Figure_4.tif (684.27 kB)
Effects of lectin-like oxidized LDL receptor-1 (LOX-1) inhibition in human aortic endothelial cells (HAECs).
figure
posted on 2013-08-08, 02:41 authored by Chih-Sheng Chu, Yu-Chen Wang, Long-Sheng Lu, Brian Walton, H. Ramazan Yilmaz, Roger Y. Huang, Tatsuya Sawamura, Richard A. F. Dixon, Wen-Ter Lai, Chu-Huang Chen, Jonathan Lu(A) HAECs were pretreated with LOX-1 neutralizing antibody TS92 before the introduction of L1 or L5 into cell culture. (B) HAECs were pretreated with TS92 before the introduction of recombinant human CRP (5 or 50 µg/mL) into cell culture. For all experiments, n = 3, and bars shown in graphs represent standard deviation. *P<0.05 vs. untreated control.
